{
  "schemaVersion": 1,
  "id": "research-403",
  "slug": "403-what-longer-follow-up-adds-to-triptorelin-research-in-early-puberty",
  "title": "What longer follow-up adds to triptorelin research in early puberty",
  "catalogLabel": "Triptorelin GnRH",
  "productCollection": "https://heritagebiolabs.com/research-library/products/triptorelin-gnrh",
  "productHandles": [
    "triptorelin-gnrh-502"
  ],
  "productUrls": [
    "https://heritagebiolabs.com/product/triptorelin-gnrh-502"
  ],
  "readingFocus": "Study findings",
  "readingFocusNote": "Reading focus is a navigational tag, not an evidence grade.",
  "wordCount": 307,
  "sourceYears": [
    2025,
    2026
  ],
  "paragraphs": [
    "Peptides are short amino-acid chains built with peptide bonds. When one activates a hormone receptor, its effect can change as the receptor adapts to prolonged stimulation. Triptorelin is a synthetic ten-amino-acid agonist of the receptor for gonadotropin-releasing hormone, or GnRH. An extended-release U.S. product, Triptodur, is approved for central precocious puberty in children age two and older. A 2026 report followed girls who received a long-acting triptorelin formulation to see how hormone measurements and physical development changed beyond the first year. [1, 2]",
    "The researchers analyzed clinical records from 37 girls. Most measured luteinizing hormone results met the study's suppression criterion. Two girls had values above that criterion at one earlier assessment and fell below it on subsequent measurements. Estradiol was generally suppressed in the samples that were taken. Breast development stabilized or regressed for most girls, while a smaller group showed further development. Each of those findings describes a particular measure. The sample included girls with different lengths of follow-up and some missing measurements at individual time points. [1]",
    "The researchers also compared bone age with chronological age. They found the average gap narrowed over time by that measure, and predicted adult height rose by an average of roughly five centimeters. A height prediction is based on the growth and bone-age measurements available during childhood. It can change as a child's growth pattern changes, and the estimate in this study cannot be read as a measured difference in adult height. [1]",
    "Following children for longer gives researchers a way to see whether early hormone changes persist and whether physical findings move in the same direction. Because this cohort had no comparison group, it cannot quantify a difference relative to another formulation or the course that would have occurred without treatment. Its direct contribution is the pattern observed over time in girls receiving the studied formulation. [1]"
  ],
  "sources": [
    {
      "number": 1,
      "citation": "Foreman A, Klein KO, Vargas Trujillo M. Efficacy and outcomes of 6-month triptorelin formulation in girls treated for central precocious puberty for 24 months and beyond. Journal of Pediatric Endocrinology and Metabolism (publication 2026-01-26).",
      "url": "https://pubmed.ncbi.nlm.nih.gov/41578923/"
    },
    {
      "number": 2,
      "citation": "Azurity Pharmaceuticals, Inc. TRIPTODUR (triptorelin) for extended-release injectable suspension, for intramuscular use. DailyMed (label updated 2025-09-14).",
      "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f41380e7-b830-432d-a5f5-a872932f107e"
    }
  ],
  "canonicalUrl": "https://heritagebiolabs.com/research-library/articles/403-what-longer-follow-up-adds-to-triptorelin-research-in-early-puberty",
  "markdownUrl": "https://heritagebiolabs.com/research-library/data/articles/403-what-longer-follow-up-adds-to-triptorelin-research-in-early-puberty.md",
  "jsonUrl": "https://heritagebiolabs.com/research-library/data/articles/403-what-longer-follow-up-adds-to-triptorelin-research-in-early-puberty.json",
  "provenance": {
    "sourceArchive": "Peptide Research Articles - All 82 Volumes.zip",
    "sourceArchiveSha256": "9796bec477cbe2f8017dda81c7e58260985a13bdda1f934e8eb8d0549c2cada5",
    "sourceVolume": "Peptide Research Articles 081 - Triptorelin GnRH.docx",
    "sourceArticleNumber": 403,
    "contentSha256": "fa812a2bb94d7d3eb593a43c23c01ad650d9f3e5cbde0e04992661fef1e59fa3",
    "statement": "Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed."
  },
  "scope": "Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend."
}
